Deals and Alliances Announced by Boehringer Ingelheim GmbH Between 2000 and 2005.DUBLIN Dublin, city, Republic of Ireland Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River. , Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles. -- Research and Markets (http://www.researchandmarkets.com/reports/c26148) has announced the addition of Boehringer Ingelheim GmbH GmbH Gesellschaft mit Beschränkter Haftung (German: limited liability company; business entity) Deals Briefing to their offering Boehringer Ingelheim GmbH Deals briefing provides an in-depth in-depth adj. Detailed; thorough: an in-depth study. in-depth Adjective detailed or thorough: an in-depth analysis view of the 79 deals made by Boehringer Ingelheim GmbH and its subsidiaries with 89 partnering companies between 2000 and 2005, in a clear and accessible PDF (Portable Document Format) The de facto standard for document publishing from Adobe. On the Web, there are countless brochures, data sheets, white papers and technical manuals in the PDF format. format. Chapter 1: Company profile --An overview of the company, including contact details, a summary of business and partnering interests, and a review of management Chapter 2: Financial data and deals overview --A summary of the company's financial status and overview of the numbers of deals by deal type, therapy focus, deal stage and industry sector. Chapter 3: Summary of deals --A comprehensive overview listing deals by Partner Company, therapy focus and development stage, with a full index of all the deals announced. Chapter 4: List of deals --A detailed listing of all the company's deals and alliances announced between January January: see month. 2000 and July July: see month. 2005. Key questions answered --Boehringer Ingelheim GmbH Deals briefing provides a comprehensive summary of the deals and alliances announced by the company and its subsidiaries between January 2000 and July 2005. This report helps in: --identifying active partners --tracking competitor activity --benchmarking deals --comparing the finances of different deal types. Boehringer Ingelheim GmbH Deals briefing brings all relevant partnering deals into one place, providing a reference to deal making by Boehringer Ingelheim GmbH. Forecasts, projections, market estimates This report provides: a financial summary table detailing the yearly total revenues, pharma revenues, R&D spend and profit of the company; and a series of tables detailing the number of deals made by deal type, by therapy focus, by development stage and by industry sector. Who should read this report? This report is essential reading for board and executive management, and individuals in: --Business Development --Licensing/partnering --Deal making --Business Strategy --Marketing and Promotion --Distribution and Manufacturing (including contract services). Profiles available on: --Bedford Laboratories --Boehringer Ingelheim (Canada Canada (kăn`ədə), independent nation (2001 pop. 30,007,094), 3,851,787 sq mi (9,976,128 sq km), N North America. Canada occupies all of North America N of the United States (and E of Alaska) except for Greenland and the French islands of ) Ltd --Boehringer Ingelheim Austria Austria (ô`strēə), Ger. Österreich [eastern march], officially Republic of Austria, federal republic (2005 est. pop. 8,185,000), 32,374 sq mi (83,849 sq km), central Europe. GmbH --Boehringer Ingelheim microParts GmbH --Boehringer Ingelheim Pharma KG --Boehringer Ingelheim Pharmaceuticals Inc --Boehringer Ingelheim Shionogi Vetmedica --Roxane Laboratories --SS Pharmaceutical Co Ltd --STEAG microParts GmbH For more information visit http://www.researchandmarkets.com/reports/c26148 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion